{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:48:34Z","timestamp":1760784514984,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":207,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493987320"},{"type":"electronic","value":"9781493987337"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/7653_2018_14","type":"book-chapter","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T11:30:05Z","timestamp":1529321405000},"page":"155-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advanced Chemometric Modeling Approaches for the Design of Multitarget Drugs Against Neurodegenerative Diseases"],"prefix":"10.1007","author":[{"given":"Amit Kumar","family":"Halder","sequence":"first","affiliation":[]},{"given":"Ana S.","family":"Moura","sequence":"additional","affiliation":[]},{"given":"M. Nat\u00e1lia D. S.","family":"Cordeiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"issue":"5","key":"14_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/dmm.030205","volume":"10","author":"AD Gitler","year":"2017","unstructured":"Gitler AD, Dhillon P, Shorter J (2017) Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech 10(5):499\u2013502","journal-title":"Dis Model Mech"},{"key":"14_CR2","first-page":"1","volume-title":"Drug discovery approaches for the treatment of neurodegenerative disorders","author":"TA Yacoubian","year":"2017","unstructured":"Yacoubian TA (2017) Chapter 1 \u2013 neurodegenerative disorders: why do we need new therapies? A2 \u2013 Adejare, Adeboye. In: Drug discovery approaches for the treatment of neurodegenerative disorders. Academic Press, New York, pp 1\u201316"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","volume":"131","author":"R Lardenoije","year":"2015","unstructured":"Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HW, Mastroeni D, Coleman P, Lemere CA, Hof PR, van den Hove DL, Rutten BP (2015) The epigenetics of aging and neurodegeneration. Prog Neurobiol 131:21\u201364","journal-title":"Prog Neurobiol"},{"issue":"10","key":"14_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4155\/fmc-2017-0099","volume":"9","author":"R Coleby","year":"2017","unstructured":"Coleby R (2017) Medicinal chemistry advances in neurodegenerative disease therapy: part 2. Future Med Chem 9(10):951\u2013952","journal-title":"Future Med Chem"},{"issue":"2","key":"14_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/14760584.2016.1229602","volume":"16","author":"JI Arevalo-Villalobos","year":"2017","unstructured":"Arevalo-Villalobos JI, Rosales-Mendoza S, Zarazua S (2017) Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals. Expert Rev Vaccines 16(2):151\u2013159","journal-title":"Expert Rev Vaccines"},{"key":"14_CR6","unstructured":"http:\/\/www.alz.co.uk\/research\/statistics"},{"issue":"1","key":"14_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/ane.12545","volume":"135","author":"AE Pen","year":"2017","unstructured":"Pen AE, Jensen UB (2017) Current status of treating neurodegenerative disease with induced pluripotent stem cells. Acta Neurol Scand 135(1):57\u201372","journal-title":"Acta Neurol Scand"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ejmech.2016.08.006","volume":"124","author":"H Khanam","year":"2016","unstructured":"Khanam H, Ali A, Asif M, Shamsuzzaman (2016) Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: a review. Eur J Med Chem 124:1121\u20131141","journal-title":"Eur J Med Chem"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","volume":"8","author":"J Cummings","year":"2016","unstructured":"Cummings J, Aisen PS, DuBois B, Frolich L, Jack CR Jr, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P (2016) Drug development in Alzheimer\u2019s disease: the path to 2025. Alzheimers Res Ther 8:39","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"14_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14737175.2016.1227705","volume":"17","author":"S Mathis","year":"2017","unstructured":"Mathis S, Couratier P, Julian A, Vallat JM, Corcia P, Le Masson G (2017) Management and therapeutic perspectives in amyotrophic lateral sclerosis. Expert Rev Neurother 17(3):263\u2013276","journal-title":"Expert Rev Neurother"},{"issue":"19","key":"14_CR11","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","volume":"57","author":"A Anighoro","year":"2014","unstructured":"Anighoro A, Bajorath J, Rastelli G (2014) Polypharmacology: challenges and opportunities in drug discovery. J Med Chem 57(19):7874\u20137887","journal-title":"J Med Chem"},{"issue":"3","key":"14_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"A Cavalli","year":"2008","unstructured":"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C (2008) Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 51(3):347\u2013372","journal-title":"J Med Chem"},{"issue":"21","key":"14_CR13","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.2174\/1381612822666160224142323","volume":"22","author":"A Lauria","year":"2016","unstructured":"Lauria A, Bonsignore R, Bartolotta R, Perricone U, Martorana A, Gentile C (2016) Drugs polypharmacology by in silico methods: new opportunities in drug discovery. Curr Pharm Des 22(21):3073\u20133081","journal-title":"Curr Pharm Des"},{"key":"14_CR14","volume-title":"Methods in molecular biology","author":"SD Satyanarayanajois","year":"2011","unstructured":"Satyanarayanajois SD (2011) Drug design and discovery: methods and protocols. In: Methods in molecular biology, vol vol 716. Humana Press, New York"},{"key":"14_CR15","volume-title":"Method in molecular biology","author":"Y Zheng","year":"2012","unstructured":"Zheng Y (2012) Rational drug design: methods and protocols. In: Method in molecular biology, vol vol 928. Humana Press, Springer, New York"},{"issue":"18","key":"14_CR16","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.4155\/fmc.15.157","volume":"7","author":"J Bajorath","year":"2015","unstructured":"Bajorath J (2015) Pushing the boundaries of computational approaches: special focus issue on computational chemistry and computer-aided drug discovery. Future Med Chem 7(18):2415\u20132417","journal-title":"Future Med Chem"},{"issue":"15","key":"14_CR17","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4155\/fmc-2013-0123","volume":"8","author":"J Bajorath","year":"2016","unstructured":"Bajorath J (2016) Computational chemistry and computer-aided drug discovery: part II. Future Med Chem 8(15):1799\u20131800","journal-title":"Future Med Chem"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-981-10-5187-6_9","volume-title":"Drug design: principles and applications","author":"S Jamal","year":"2017","unstructured":"Jamal S, Grover A (2017) Cheminformatics approaches in modern drug discovery. In: Grover A (ed) Drug design: principles and applications. Springer Singapore, Singapore, pp 135\u2013148"},{"issue":"12","key":"14_CR19","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M, Dearden J, Gramatica P, Martin YC, Todeschini R, Consonni V, Kuz\u2019min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, Gasteiger J, Richard A, Tropsha A (2014) QSAR modeling: where have you been? Where are you going to? J Med Chem 57(12):4977\u20135010","journal-title":"J Med Chem"},{"key":"14_CR20","series-title":"ACS symposium series","doi-asserted-by":"publisher","DOI":"10.1021\/bk-2005-0894","volume-title":"Chemometrics and chemoinformatics","author":"BK Lavine","year":"2005","unstructured":"Lavine BK (2005) Chemometrics and chemoinformatics, ACS symposium series, vol vol 894. American Chemical Society, Washington, DC"},{"issue":"suppl C","key":"14_CR21","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.proeng.2012.06.156","volume":"38","author":"BF Begam","year":"2012","unstructured":"Begam BF, Kumar JS (2012) A study on cheminformatics and its applications on modern drug discovery. Procedia Eng 38(suppl C):1264\u20131275","journal-title":"Procedia Eng"},{"issue":"7","key":"14_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9(7):a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","volume":"69","author":"LI Labzin","year":"2017","unstructured":"Labzin LI, Heneka MT, Latz E (2017) Innate immunity and neurodegeneration. Annu Rev Med 69:437\u2013449","journal-title":"Annu Rev Med"},{"issue":"Pt 3","key":"14_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/brain\/awq383","volume":"134","author":"G Chetelat","year":"2011","unstructured":"Chetelat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC, Australian Imaging B, Lifestyle Study of Ageing Research G (2011) Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer\u2019s disease. Brain 134(Pt 3):798\u2013807","journal-title":"Brain"},{"issue":"6","key":"14_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/13554791003730600","volume":"16","author":"KL Possin","year":"2010","unstructured":"Possin KL (2010) Visual spatial cognition in neurodegenerative disease. Neurocase 16(6):466\u2013487","journal-title":"Neurocase"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:S10","journal-title":"Nat Med"},{"issue":"14","key":"14_CR27","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00018-009-0020-8","volume":"66","author":"KT Jacobsen","year":"2009","unstructured":"Jacobsen KT, Iverfeldt K (2009) Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell Mol Life Sci 66(14):2299\u20132318","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"14_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-130746","volume":"37","author":"AJ Larner","year":"2013","unstructured":"Larner AJ (2013) Presenilin-1 mutations in Alzheimer\u2019s disease: an update on genotype-phenotype relationships. J Alzheimers Dis 37(4):653\u2013659","journal-title":"J Alzheimers Dis"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/B978-0-12-802810-0.00007-6","volume-title":"Drug discovery approaches for the treatment of neurodegenerative disorders","author":"AO Adeniji","year":"2017","unstructured":"Adeniji AO, Adams PW, Mody VV (2017) Chapter 7 \u2013 amyloid \u03b2 hypothesis in the development of therapeutic agents for Alzheimer\u2019s disease A2 \u2013 Adejare, Adeboye. In: Drug discovery approaches for the treatment of neurodegenerative disorders. Academic Press, New York, pp 109\u2013143"},{"issue":"9996","key":"14_CR30","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"issue":"3","key":"14_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/ane.12616","volume":"135","author":"M Ferreira","year":"2017","unstructured":"Ferreira M, Massano J (2017) An updated review of Parkinson\u2019s disease genetics and clinicopathological correlations. Acta Neurol Scand 135(3):273\u2013284","journal-title":"Acta Neurol Scand"},{"issue":"6645","key":"14_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"2","key":"14_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 111(2):145\u2013151","journal-title":"J Clin Invest"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"14_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398","journal-title":"Lancet Neurol"},{"issue":"16","key":"14_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gnf082","volume":"30","author":"E Moncke-Buchner","year":"2002","unstructured":"Moncke-Buchner E, Reich S, Mucke M, Reuter M, Messer W, Wanker EE, Kruger DH (2002) Counting CAG repeats in the Huntington\u2019s disease gene by restriction endonuclease EcoP15I cleavage. Nucleic Acids Res 30(16):e83","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"14_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1468-1331.2009.02801.x","volume":"17","author":"M Witgert","year":"2010","unstructured":"Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, Mosnik D, Appel SH, Schulz PE (2010) Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol 17(1):103\u2013110","journal-title":"Eur J Neurol"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171","journal-title":"Surg Neurol Int"},{"issue":"3","key":"14_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","volume":"172","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Budka H (2008) Prion diseases: from protein to cell pathology. Am J Pathol 172(3):555\u2013565","journal-title":"Am J Pathol"},{"issue":"11","key":"14_CR40","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0609241104","volume":"104","author":"P Piccardo","year":"2007","unstructured":"Piccardo P, Manson JC, King D, Ghetti B, Barron RM (2007) Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 104(11):4712\u20134717","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR41","first-page":"113","volume":"8","author":"S Stayte","year":"2014","unstructured":"Stayte S, Vissel B (2014) Advances in non-dopaminergic treatments for Parkinson\u2019s disease. Front Neurosci 8:113","journal-title":"Front Neurosci"},{"issue":"4","key":"14_CR42","first-page":"208","volume":"35","author":"DA Casey","year":"2010","unstructured":"Casey DA, Antimisiaris D, O\u2019Brien J (2010) Drugs for Alzheimer\u2019s disease: are they effective? P T 35(4):208\u2013211","journal-title":"P T"},{"issue":"1","key":"14_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6(1):19\u201333","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"14_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","volume":"3","author":"J Cummings","year":"2017","unstructured":"Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K (2017) Alzheimer\u2019s disease drug development pipeline: 2017. Alzheimers Dement (N Y) 3(3):367\u2013384","journal-title":"Alzheimers Dement (N Y)"},{"issue":"15","key":"14_CR45","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC, Quality Standards Subcommittee of the American Academy of N (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218\u20131226","journal-title":"Neurology"},{"issue":"5","key":"14_CR46","first-page":"545","volume":"3","author":"D Paleacu","year":"2007","unstructured":"Paleacu D (2007) Tetrabenazine in the treatment of Huntington\u2019s disease. Neuropsychiatr Dis Treat 3(5):545\u2013551","journal-title":"Neuropsychiatr Dis Treat"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6904-5-3","volume":"5","author":"SK Mencher","year":"2005","unstructured":"Mencher SK, Wang LG (2005) Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol 5:3","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"14_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040262","volume":"7","author":"JJ Lu","year":"2012","unstructured":"Lu JJ, Pan W, Hu YJ, Wang YT (2012) Multi-target drugs: the trend of drug research and development. PLoS One 7(6):e40262","journal-title":"PLoS One"},{"issue":"12","key":"14_CR49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/embor.2013.177","volume":"14","author":"R Iyengar","year":"2013","unstructured":"Iyengar R (2013) Complex diseases require complex therapies. EMBO Rep 14(12):1039\u20131042","journal-title":"EMBO Rep"},{"issue":"21","key":"14_CR50","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"R Morphy","year":"2005","unstructured":"Morphy R, Rankovic Z (2005) Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem 48(21):6523\u20136543","journal-title":"J Med Chem"},{"issue":"13","key":"14_CR51","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.2174\/0929867311320130004","volume":"20","author":"ML Bolognesi","year":"2013","unstructured":"Bolognesi ML (2013) Polypharmacology in a single drug: multitarget drugs. Curr Med Chem 20(13):1639\u20131645","journal-title":"Curr Med Chem"},{"issue":"1","key":"14_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith CT, Borisy AA, Stockwell BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4(1):71\u201378","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"14_CR53","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1021\/jm050148z","volume":"48","author":"P Smid","year":"2005","unstructured":"Smid P, Coolen HK, Keizer HG, van Hes R, de Moes JP, den Hartog AP, Stork B, Plekkenpol RH, Niemann LC, Stroomer CN, Tulp MT, van Stuivenberg HH, McCreary AC, Hesselink MB, Herremans AH, Kruse CG (2005) Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition. J Med Chem 48(22):6855\u20136869","journal-title":"J Med Chem"},{"issue":"R1","key":"14_CR54","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1093\/hmg\/ddq162","volume":"19","author":"S Tsuji","year":"2010","unstructured":"Tsuji S (2010) Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet 19(R1):R65\u2013R70","journal-title":"Hum Mol Genet"},{"issue":"3","key":"14_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/ecp.11.13","volume":"4","author":"CJ Van der Schyf","year":"2011","unstructured":"Van der Schyf CJ (2011) The use of multi-target drugs in the treatment of neurodegenerative diseases. Expert Rev Clin Pharmacol 4(3):293\u2013298","journal-title":"Expert Rev Clin Pharmacol"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.2741\/3069","volume":"13","author":"O Weinreb","year":"2008","unstructured":"Weinreb O, Amit T, Bar-Am O, Yogev-Falach M, Youdim MB (2008) The neuroprotective mechanism of action of the multimodal drug ladostigil. Front Biosci 13:5131\u20135137","journal-title":"Front Biosci"},{"issue":"7","key":"14_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1039\/C4MD00069B","volume":"5","author":"F Prati","year":"2014","unstructured":"Prati F, Uliassi E, Bolognesi ML (2014) Two diseases, one approach: multitarget drug discovery in Alzheimer\u2019s and neglected tropical diseases. MedChemComm 5(7):853\u2013861","journal-title":"MedChemComm"},{"key":"14_CR58","unstructured":"Beebe KR, Pell RJ, Seasholtz MB (1998) Chemometrics: A practical guide. John Wiley & Sons, Inc., New York"},{"issue":"1","key":"14_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pca.2378","volume":"24","author":"HA Gad","year":"2013","unstructured":"Gad HA, El-Ahmady SH, Abou-Shoer MI, Al-Azizi MM (2013) Application of chemometrics in authentication of herbal medicines: a review. Phytochem Anal 24(1):1\u201324","journal-title":"Phytochem Anal"},{"issue":"6","key":"14_CR60","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jtice.2010.03.017","volume":"41","author":"H-J Huang","year":"2010","unstructured":"Huang H-J, Yu HW, Chen C-Y, Hsu C-H, Chen H-Y, Lee K-J, Tsai F-J, Chen CY-C (2010) Current developments of computer-aided drug design. J Taiwan Inst Chem Eng 41(6):623\u2013635","journal-title":"J Taiwan Inst Chem Eng"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-61779-465-0_13","volume":"819","author":"AJ Christofferson","year":"2012","unstructured":"Christofferson AJ, Huang N (2012) How to benchmark methods for structure-based virtual screening of large compound libraries. Methods Mol Biol 819:187\u2013195","journal-title":"Methods Mol Biol"},{"issue":"9","key":"14_CR62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2174\/1568026611313090009","volume":"13","author":"AK Halder","year":"2013","unstructured":"Halder AK, Saha A, Jha T (2013) The role of 3D pharmacophore mapping based virtual screening for identification of novel anticancer agents: an overview. Curr Top Med Chem 13(9):1098\u20131126","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"14_CR63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337\u2013341","journal-title":"Drug Discov Today Technol"},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/194178b0","volume":"194","author":"C Hansch","year":"1962","unstructured":"Hansch C, Maloney PP, Fujita T, Muir RM (1962) Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature 194:178","journal-title":"Nature"},{"issue":"1","key":"14_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10822-011-9495-0","volume":"26","author":"RD Cramer","year":"2012","unstructured":"Cramer RD (2012) The inevitable QSAR renaissance. J Comput Aided Mol Des 26(1):35\u201338","journal-title":"J Comput Aided Mol Des"},{"key":"14_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/9783527613106","volume-title":"Handbook of molecular descriptors","author":"R Todeschini","year":"2000","unstructured":"Todeschini R, Consonni V (2000) Handbook of molecular descriptors, vol 11. Wiley VCH, Weinheim"},{"issue":"49","key":"14_CR67","doi-asserted-by":"publisher","first-page":"16101","DOI":"10.1021\/ie301079r","volume":"51","author":"FA Quintero","year":"2012","unstructured":"Quintero FA, Patel SJ, Mu\u00f1oz F, Sam Mannan M (2012) Review of existing QSAR\/QSPR models developed for properties used in hazardous chemicals classification system. Ind Eng Chem Res 51(49):16101\u201316115","journal-title":"Ind Eng Chem Res"},{"issue":"6","key":"14_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/wcms.1187","volume":"4","author":"RA Lewis","year":"2014","unstructured":"Lewis RA, Wood D (2014) Modern 2D QSAR for drug discovery. Wiley Interdiscip Rev Comput Mol Sci 4(6):505\u2013522","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"issue":"18","key":"14_CR69","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110(18):5959\u20135967","journal-title":"J Am Chem Soc"},{"issue":"1","key":"14_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1008047919606","volume":"13","author":"G Klebe","year":"1999","unstructured":"Klebe G, Abraham U (1999) Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des 13(1):1\u201310","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"14_CR71","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/jm9810607","volume":"42","author":"DD Robinson","year":"1999","unstructured":"Robinson DD, Winn PJ, Lyne PD, Richards WG (1999) Self-organizing molecular field analysis: a tool for structure-activity studies. J Med Chem 42(4):573\u2013583","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/ci0501286","volume":"46","author":"S Ajmani","year":"2006","unstructured":"Ajmani S, Jadhav K, Kulkarni SA (2006) Three-dimensional QSAR using the k-nearest neighbor method and its interpretation. J Chem Inf Model 46(1):24\u201331","journal-title":"J Chem Inf Model"},{"issue":"3","key":"14_CR73","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/jm020194o","volume":"46","author":"RD Cramer","year":"2003","unstructured":"Cramer RD (2003) Topomer CoMFA: a design methodology for rapid lead optimization. J Med Chem 46(3):374\u2013388","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00894-010-0684-x","volume":"17","author":"P Tosco","year":"2011","unstructured":"Tosco P, Balle T (2011) Open3DQSAR: a new open-source software aimed at high-throughput chemometric analysis of molecular interaction fields. J Mol Model 17(1):201\u2013208","journal-title":"J Mol Model"},{"issue":"8","key":"14_CR75","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1021\/ci300246m","volume":"52","author":"M Hechinger","year":"2012","unstructured":"Hechinger M, Leonhard K, Marquardt W (2012) What is wrong with quantitative structure-property relations models based on three-dimensional descriptors? J Chem Inf Model 52(8):1984\u20131993","journal-title":"J Chem Inf Model"},{"issue":"12","key":"14_CR76","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1517\/17460441.2015.1083006","volume":"10","author":"T Wang","year":"2015","unstructured":"Wang T, Wu MB, Lin JP, Yang LR (2015) Quantitative structure-activity relationship: promising advances in drug discovery platforms. Expert Opin Drug Discov 10(12):1283\u20131300","journal-title":"Expert Opin Drug Discov"},{"issue":"17","key":"14_CR77","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1021\/jm000941m","volume":"43","author":"M Pastor","year":"2000","unstructured":"Pastor M, Cruciani G, McLay I, Pickett S, Clementi S (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43(17):3233\u20133243","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR78","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/ci500574n","volume":"55","author":"J Fang","year":"2015","unstructured":"Fang J, Li Y, Liu R, Pang X, Li C, Yang R, He Y, Lian W, Liu A-L, Du G-H (2015) Discovery of multitarget-directed ligands against Alzheimer\u2019s disease through systematic prediction of chemical\u2013protein interactions. J Chem Inf Model 55(1):149\u2013164","journal-title":"J Chem Inf Model"},{"issue":"16","key":"14_CR79","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2174\/0929867324666170124152746","volume":"24","author":"A Speck-Planche","year":"2017","unstructured":"Speck-Planche A, Cordeiro MNDS (2017) Advanced in silico approaches for drug discovery: mining information from multiple biological and chemical data through mtk-QSBER and pt-QSPR strategies. Curr Med Chem 24(16):1687\u20131704","journal-title":"Curr Med Chem"},{"issue":"3","key":"14_CR80","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/17460441.2015.1006195","volume":"10","author":"A Speck-Planche","year":"2015","unstructured":"Speck-Planche A, Cordeiro MNDS (2015) Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery. Expert Opin Drug Discov 10(3):245\u2013256","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"14_CR81","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.jcim.5b00630","volume":"56","author":"A Speck-Planche","year":"2016","unstructured":"Speck-Planche A, Kleandrova VV, Ruso JM, Cordeiro MNDS (2016) First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple gram-positive pathogens. J Chem Inf Model 56(3):588\u2013598","journal-title":"J Chem Inf Model"},{"issue":"12","key":"14_CR82","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1021\/acs.molpharmaceut.7b00582","volume":"14","author":"D Antanasijevic","year":"2017","unstructured":"Antanasijevic D, Antanasijevic J, Trisovic N, Uscumlic G, Pocajt V (2017) From classification to regression multitasking QSAR modeling using a novel modular neural network: simultaneous prediction of anticonvulsant activity and neurotoxicity of succinimides. Mol Pharm 14(12):4476\u20134484","journal-title":"Mol Pharm"},{"issue":"3","key":"14_CR83","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1389203717999160226173500","volume":"17","author":"GM Casanola-Martin","year":"2016","unstructured":"Casanola-Martin GM, Le-Thi-Thu H, Perez-Gimenez F, Marrero-Ponce Y, Merino-Sanjuan M, Abad C, Gonzalez-Diaz H (2016) Multi-output model with box-Jenkins operators of quadratic indices for prediction of malaria and cancer inhibitors targeting ubiquitin-proteasome pathway (UPP) proteins. Curr Protein Pept Sci 17(3):220\u2013227","journal-title":"Curr Protein Pept Sci"},{"issue":"2","key":"14_CR84","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11030-015-9571-9","volume":"19","author":"GM Casanola-Martin","year":"2015","unstructured":"Casanola-Martin GM, Le-Thi-Thu H, Perez-Gimenez F, Marrero-Ponce Y, Merino-Sanjuan M, Abad C, Gonzalez-Diaz H (2015) Multi-output model with box-Jenkins operators of linear indices to predict multi-target inhibitors of ubiquitin-proteasome pathway. Mol Divers 19(2):347\u2013356","journal-title":"Mol Divers"},{"issue":"21","key":"14_CR85","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.2174\/1381612822666160224141930","volume":"22","author":"H Wathieu","year":"2016","unstructured":"Wathieu H, Issa NT, Byers SW, Dakshanamurthy S (2016) Harnessing polypharmacology with computer-aided drug design and systems biology. Curr Pharm Des 22(21):3097\u20133108","journal-title":"Curr Pharm Des"},{"issue":"8","key":"14_CR86","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/jm960352+","volume":"40","author":"H Matter","year":"1997","unstructured":"Matter H (1997) Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. J Med Chem 40(8):1219\u20131229","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","volume":"7","author":"D Bajusz","year":"2015","unstructured":"Bajusz D, R\u00e1cz A, H\u00e9berger K (2015) Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminform 7(1):20","journal-title":"J Cheminform"},{"issue":"2","key":"14_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25(2):197\u2013206","journal-title":"Nat Biotechnol"},{"issue":"1","key":"14_CR89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12859-017-1586-z","volume":"18","author":"T Huang","year":"2017","unstructured":"Huang T, Mi H, Lin CY, Zhao L, Zhong LL, Liu FB, Zhang G, Lu AP, Bian ZX, for MG (2017) MOST: most-similar ligand based approach to target prediction. BMC Bioinformatics 18(1):165","journal-title":"BMC Bioinformatics"},{"issue":"11\u201312","key":"14_CR90","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15(11\u201312):444\u2013450","journal-title":"Drug Discov Today"},{"issue":"7","key":"14_CR91","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/1381612013397843","volume":"7","author":"JS Mason","year":"2001","unstructured":"Mason JS, Good AC, Martin EJ (2001) 3-D pharmacophores in drug discovery. Curr Pharm Des 7(7):567\u2013597","journal-title":"Curr Pharm Des"},{"issue":"88","key":"14_CR92","doi-asserted-by":"publisher","first-page":"72373","DOI":"10.1039\/C5RA12606A","volume":"5","author":"AK Halder","year":"2015","unstructured":"Halder AK, Mallick S, Shikha D, Saha A, Saha KD, Jha T (2015) Design of dual MMP-2\/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity. RSC Adv 5(88):72373\u201372386","journal-title":"RSC Adv"},{"key":"14_CR93","unstructured":"http:\/\/59.78.96.61\/pharmmapper\/"},{"issue":"9","key":"14_CR94","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10822-006-9082-y","volume":"20","author":"NJ Richmond","year":"2006","unstructured":"Richmond NJ, Abrams CA, Wolohan PR, Abrahamian E, Willett P, Clark RD (2006) GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des 20(9):567\u2013587","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"14_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01533070","volume":"3","author":"JH Van Drie","year":"1989","unstructured":"Van Drie JH, Weininger D, Martin YC (1989) ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures. J Comput Aided Mol Des 3(3):225\u2013251","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"14_CR96","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/BF00134184","volume":"10","author":"JH Van Drie","year":"1996","unstructured":"Van Drie JH (1996) An inequality for 3D database searching and its use in evaluating the treatment of conformational flexibility. J Comput Aided Mol Des 10(6):623\u2013630","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"14_CR97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00141577","volume":"7","author":"YC Martin","year":"1993","unstructured":"Martin YC, Bures MG, Danaher EA, DeLazzer J, Lico I, Pavlik PA (1993) A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J Comput Aided Mol Des 7(1):83\u2013102","journal-title":"J Comput Aided Mol Des"},{"issue":"10","key":"14_CR98","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/ci900212v","volume":"49","author":"NK Salam","year":"2009","unstructured":"Salam NK, Nuti R, Sherman W (2009) Novel method for generating structure-based pharmacophores using energetic analysis. J Chem Inf Model 49(10):2356\u20132368","journal-title":"J Chem Inf Model"},{"issue":"6","key":"14_CR99","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF00124324","volume":"9","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comput Aided Mol Des 9(6):532\u2013549","journal-title":"J Comput Aided Mol Des"},{"issue":"3","key":"14_CR100","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/ci950273r","volume":"36","author":"D Barnum","year":"1996","unstructured":"Barnum D, Greene J, Smellie A, Sprague P (1996) Identification of common functional configurations among molecules. J Chem Inf Comput Sci 36(3):563\u2013571","journal-title":"J Chem Inf Comput Sci"},{"key":"14_CR101","volume-title":"Pharmacophore perception, development and use in drug design","author":"H Li","year":"2000","unstructured":"Li H, Sutter J, Hoffman R (2000) HypoGen: an automated system for generating 3D predictive pharmacophore models. In: Guner O (ed) Pharmacophore perception, development and use in drug design. International University Line, La Jolla, CA"},{"issue":"1","key":"14_CR102","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45(1):160\u2013169","journal-title":"J Chem Inf Model"},{"key":"14_CR103","unstructured":"Molecular Operating Environment (MOE). Chemical Computing Group. www.chemcomp.com"},{"issue":"4","key":"14_CR104","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1093-3263(97)00080-6","volume":"15","author":"JD Holliday","year":"1997","unstructured":"Holliday JD, Willett P (1997) Using a genetic algorithm to identify common structural features in sets of ligands. J Mol Graph Model 15(4):221\u2013232","journal-title":"J Mol Graph Model"},{"issue":"10\u201311","key":"14_CR105","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20(10\u201311):647\u2013671","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"14_CR106","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","volume":"36","author":"YC Chen","year":"2015","unstructured":"Chen YC (2015) Beware of docking! Trends Pharmacol Sci 36(2):78\u201395","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"14_CR107","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1021\/ci500406k","volume":"54","author":"J Gabel","year":"2014","unstructured":"Gabel J, Desaphy J, Rognan D (2014) Beware of machine learning-based scoring functions-on the danger of developing black boxes. J Chem Inf Model 54(10):2807\u20132815","journal-title":"J Chem Inf Model"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13321-016-0139-1","volume":"8","author":"MR Koebel","year":"2016","unstructured":"Koebel MR, Schmadeke G, Posner RG, Sirimulla S (2016) AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina. J Cheminform 8:27","journal-title":"J Cheminform"},{"issue":"6","key":"14_CR109","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1261\/rna.1563609","volume":"15","author":"PT Lang","year":"2009","unstructured":"Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, Rizzo RC, Case DA, James TL, Kuntz ID (2009) DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15(6):1219\u20131230","journal-title":"RNA"},{"issue":"3","key":"14_CR110","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"M Rarey","year":"1996","unstructured":"Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261(3):470\u2013489","journal-title":"J Mol Biol"},{"issue":"8","key":"14_CR111","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","volume":"26","author":"M McGann","year":"2012","unstructured":"McGann M (2012) FRED and HYBRID docking performance on standardized datasets. J Comput Aided Mol Des 26(8):897\u2013906","journal-title":"J Comput Aided Mol Des"},{"key":"14_CR112","unstructured":"Schrodinger release 2017-1: Glide. Schrodinger, LLC, New York, NY, 2017"},{"issue":"4","key":"14_CR113","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein-ligand docking using GOLD. Proteins 52(4):609\u2013623","journal-title":"Proteins"},{"issue":"4","key":"14_CR114","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1093-3263(02)00164-X","volume":"21","author":"CM Venkatachalam","year":"2003","unstructured":"Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 21(4):289\u2013307","journal-title":"J Mol Graph Model"},{"issue":"5","key":"14_CR115","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10822-007-9114-2","volume":"21","author":"AN Jain","year":"2007","unstructured":"Jain AN (2007) Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J Comput Aided Mol Des 21(5):281\u2013306","journal-title":"J Comput Aided Mol Des"},{"key":"14_CR116","unstructured":"VLifeMDS: molecular design suite. VLife Sciences Technologies Pvt. Ltd., Pune, India, 2010"},{"key":"14_CR117","unstructured":"https:\/\/www.schrodinger.com\/sitemap"},{"key":"14_CR118","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gks441","volume":"40(web server i","author":"CH Ngan","year":"2012","unstructured":"Ngan CH, Bohnuud T, Mottarella SE, Beglov D, Villar EA, Hall DR, Kozakov D, Vajda S (2012) FTMAP: extended protein mapping with user-selected probe molecules. Nucleic Acids Res 40(web server issue):W271\u2013W275","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"14_CR119","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta E, Spyrou G, Vassilatis DK, Cournia Z (2014) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14(16):1923\u20131938","journal-title":"Curr Top Med Chem"},{"key":"14_CR120","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2105-10-168","volume":"10","author":"V Le Guilloux","year":"2009","unstructured":"Le Guilloux V, Schmidtke P, Tuffery P (2009) Fpocket: an open source platform for ligand pocket detection. BMC Bioinformatics 10:168","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"14_CR121","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156802610790232279","volume":"10","author":"RE Amaro","year":"2010","unstructured":"Amaro RE, Li WW (2010) Emerging methods for ensemble-based virtual screening. Curr Top Med Chem 10(1):3\u201313","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"14_CR122","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely P, Agoston V, Pongor S (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26(4):178\u2013182","journal-title":"Trends Pharmacol Sci"},{"key":"14_CR123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1741-7007-9-71","volume":"9","author":"JD Durrant","year":"2011","unstructured":"Durrant JD, McCammon JA (2011) Molecular dynamics simulations and drug discovery. BMC Biol 9:71","journal-title":"BMC Biol"},{"key":"14_CR124","unstructured":"http:\/\/bidd.nus.edu.sg\/group\/softwares\/invdock.htm"},{"key":"14_CR125","doi-asserted-by":"publisher","first-page":"W393","DOI":"10.1093\/nar\/gks496","volume":"40(web server i","author":"JC Wang","year":"2012","unstructured":"Wang JC, Chu PY, Chen CM, Lin JH (2012) idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach. Nucleic Acids Res 40(web server issue):W393\u2013W399","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"14_CR126","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1142\/S0192415X02000156","volume":"30","author":"YZ Chen","year":"2002","unstructured":"Chen YZ, Ung CY (2002) Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants. Am J Chin Med 30(1):139\u2013154","journal-title":"Am J Chin Med"},{"issue":"3","key":"14_CR127","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17460441.2017.1280024","volume":"12","author":"R Chaudhari","year":"2017","unstructured":"Chaudhari R, Tan Z, Huang B, Zhang S (2017) Computational polypharmacology: a new paradigm for drug discovery. Expert Opin Drug Discov 12(3):279\u2013291","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"14_CR128","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/bioinformatics\/btv616","volume":"32","author":"M Chartier","year":"2016","unstructured":"Chartier M, Adriansen E, Najmanovich R (2016) IsoMIF finder: online detection of binding site molecular interaction field similarities. Bioinformatics 32(4):621\u2013623","journal-title":"Bioinformatics"},{"key":"14_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13321-017-0199-x","volume":"9","author":"M Awale","year":"2017","unstructured":"Awale M, Reymond JL (2017) The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data. J Cheminform 9:11","journal-title":"J Cheminform"},{"key":"14_CR130","unstructured":"http:\/\/www.ebi.ac.uk\/chembldb"},{"key":"14_CR131","unstructured":"http:\/\/pubchem.ncbi.nlm.nih.gov"},{"key":"14_CR132","unstructured":"http:\/\/insilico.charite.de\/supertarget\/"},{"key":"14_CR133","unstructured":"http:\/\/r2d2drug.org\/DMC.aspx"},{"key":"14_CR134","unstructured":"http:\/\/bidd.nus.edu.sg\/group\/cjttd"},{"key":"14_CR135","unstructured":"https:\/\/www.bindingdb.org\/"},{"key":"14_CR136","unstructured":"http:\/\/www.drugbank.ca"},{"key":"14_CR137","unstructured":"http:\/\/www.t3db.org"},{"key":"14_CR138","unstructured":"http:\/\/thomsonreuters.com\/metacore"},{"key":"14_CR139","unstructured":"http:\/\/www.biocarta.com"},{"key":"14_CR140","unstructured":"http:\/\/www.pantherdb.org"},{"key":"14_CR141","unstructured":"http:\/\/www.hmdb.ca"},{"key":"14_CR142","unstructured":"https:\/\/www.rcsb.org\/"},{"key":"14_CR143","unstructured":"http:\/\/www.uniprot.org\/"},{"issue":"6","key":"14_CR144","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/1062936X.2017.1331467","volume":"28","author":"S Bitam","year":"2017","unstructured":"Bitam S, Hamadache M, Hanini S (2017) QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors. SAR QSAR Environ Res 28(6):471\u2013489","journal-title":"SAR QSAR Environ Res"},{"key":"14_CR145","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12929-014-0084-0","volume":"21","author":"KY Wong","year":"2014","unstructured":"Wong KY, Mercader AG, Saavedra LM, Honarparvar B, Romanelli GP, Duchowicz PR (2014) QSAR analysis on tacrine-related acetylcholinesterase inhibitors. J Biomed Sci 21:84","journal-title":"J Biomed Sci"},{"issue":"2","key":"14_CR146","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11224-014-0494-3","volume":"26","author":"C Vats","year":"2015","unstructured":"Vats C, Dhanjal JK, Goyal S, Bharadvaja N, Grover A (2015) Computational design of novel flavonoid analogues as potential AChE inhibitors: analysis using group-based QSAR, molecular docking and molecular dynamics simulations. Struct Chem 26(2):467\u2013476","journal-title":"Struct Chem"},{"issue":"10","key":"14_CR147","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1007\/s00044-016-1620-0","volume":"25","author":"N Mahmoodabadi","year":"2016","unstructured":"Mahmoodabadi N, Ajloo D (2016) QSAR, docking, and molecular dynamic studies on the polyphenolic as inhibitors of \u03b2-amyloid aggregation. Med Chem Res 25(10):2104\u20132118","journal-title":"Med Chem Res"},{"issue":"34","key":"14_CR148","doi-asserted-by":"publisher","first-page":"28171","DOI":"10.1039\/C6RA04104C","volume":"6","author":"P Ambure","year":"2016","unstructured":"Ambure P, Roy K (2016) Understanding the structural requirements of cyclic sulfone hydroxyethylamines as hBACE1 inhibitors against A[small beta] plaques in Alzheimer\u2019s disease: a predictive QSAR approach. RSC Adv 6(34):28171\u201328186","journal-title":"RSC Adv"},{"key":"14_CR149","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.compbiomed.2015.06.019","volume":"64","author":"MA Toropova","year":"2015","unstructured":"Toropova MA, Toropov AA, Raska I Jr, Raskova M (2015) Searching therapeutic agents for treatment of Alzheimer disease using the Monte Carlo method. Comput Biol Med 64:148\u2013154","journal-title":"Comput Biol Med"},{"issue":"2","key":"14_CR150","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11030-017-9732-0","volume":"21","author":"B Niu","year":"2017","unstructured":"Niu B, Zhao M, Su Q, Zhang M, Lv W, Chen Q, Chen F, Chu D, Du D, Zhang Y (2017) 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors. Mol Divers 21(2):413\u2013426","journal-title":"Mol Divers"},{"issue":"13","key":"14_CR151","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1039\/C3RA46861E","volume":"4","author":"P Ambure","year":"2014","unstructured":"Ambure P, Roy K (2014) Exploring structural requirements of leads for improving activity and selectivity against CDK5\/p25 in Alzheimer\u2019s disease: an in silico approach. RSC Adv 4(13):6702\u20136709","journal-title":"RSC Adv"},{"issue":"4","key":"14_CR152","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1007\/s00044-012-0166-z","volume":"22","author":"P Jain","year":"2013","unstructured":"Jain P, Jadhav HR (2013) Quantitative structure activity relationship analysis of aminoimidazoles as BACE-I inhibitors. Med Chem Res 22(4):1740\u20131746","journal-title":"Med Chem Res"},{"issue":"4","key":"14_CR153","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11030-017-9772-5","volume":"21","author":"C Cai","year":"2017","unstructured":"Cai C, Wu Q, Luo Y, Ma H, Shen J, Zhang Y, Yang L, Chen Y, Wen Z, Wang Q (2017) In silico prediction of ROCK II inhibitors by different classification approaches. Mol Divers 21(4):791\u2013807","journal-title":"Mol Divers"},{"issue":"9","key":"14_CR154","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/1062936X.2013.792877","volume":"24","author":"S Gharaghani","year":"2013","unstructured":"Gharaghani S, Khayamian T, Ebrahimi M (2013) Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. SAR QSAR Environ Res 24(9):773\u2013794","journal-title":"SAR QSAR Environ Res"},{"key":"14_CR155","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejmech.2012.10.035","volume":"59","author":"AM Helguera","year":"2013","unstructured":"Helguera AM, Perez-Garrido A, Gaspar A, Reis J, Cagide F, Vina D, Cordeiro MNDS, Borges F (2013) Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors. Eur J Med Chem 59:75\u201390","journal-title":"Eur J Med Chem"},{"issue":"8","key":"14_CR156","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00044-010-9431-1","volume":"20","author":"P Lu","year":"2011","unstructured":"Lu P, Wei X, Zhang R, Yuan Y, Gong Z (2011) Prediction of the binding affinities of adenosine A2A receptor antagonists based on the heuristic method and support vector machine. Med Chem Res 20(8):1220\u20131228","journal-title":"Med Chem Res"},{"issue":"5","key":"14_CR157","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/157340610793358891","volume":"6","author":"DA Karolidis","year":"2010","unstructured":"Karolidis DA, Agatonovic-Kustrin S, Morton DW (2010) Artificial neural network (ANN) based modelling for D1 like and D2 like dopamine receptor affinity and selectivity. Med Chem 6(5):259\u2013270","journal-title":"Med Chem"},{"issue":"16","key":"14_CR158","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.2174\/1568026611209061734","volume":"12","author":"A Speck-Planche","year":"2012","unstructured":"Speck-Planche A, Kleandrova VV (2012) QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres. Curr Top Med Chem 12(16):1734\u20131747","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"14_CR159","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/minf.201300057","volume":"33","author":"I Kahn","year":"2014","unstructured":"Kahn I, Lomaka A, Karelson M (2014) Topological fingerprints as an aid in finding structural patterns for LRRK2 inhibition. Mol Inform 33(4):269\u2013275","journal-title":"Mol Inform"},{"issue":"30","key":"14_CR160","doi-asserted-by":"publisher","first-page":"23922","DOI":"10.1039\/C5RA01098E","volume":"5","author":"VP Zambre","year":"2015","unstructured":"Zambre VP, Hambarde VA, Petkar NN, Patel CN, Sawant SD (2015) Structural investigations by in silico modeling for designing NR2B subunit selective NMDA receptor antagonists. RSC Adv 5(30):23922\u201323940","journal-title":"RSC Adv"},{"issue":"23","key":"14_CR161","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.bmcl.2016.10.058","volume":"26","author":"SA Amin","year":"2016","unstructured":"Amin SA, Adhikari N, Jha T, Gayen S (2016) First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington\u2019s disease: a proposal to chemists! Bioorg Med Chem Lett 26(23):5712\u20135718","journal-title":"Bioorg Med Chem Lett"},{"issue":"suppl 19","key":"14_CR162","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12859-016-1379-9","volume":"17","author":"K Joshi","year":"2016","unstructured":"Joshi K, Goyal S, Grover S, Jamal S, Singh A, Dhar P, Grover A (2016) Novel group-based QSAR and combinatorial design of CK-1delta inhibitors as neuroprotective agents. BMC Bioinformatics 17(suppl 19):515","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"14_CR163","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00044-012-0124-9","volume":"22","author":"A Amirhamzeh","year":"2013","unstructured":"Amirhamzeh A, Vosoughi M, Shafiee A, Amini M (2013) Synthesis and docking study of diaryl-isothiazole and 1,2,3-thiadiazole derivatives as potential neuroprotective agents. Med Chem Res 22(3):1212\u20131223","journal-title":"Med Chem Res"},{"issue":"12","key":"14_CR164","doi-asserted-by":"publisher","first-page":"9857","DOI":"10.1039\/C5RA23035G","volume":"6","author":"J Fang","year":"2016","unstructured":"Fang J, Pang X, Yan R, Lian W, Li C, Wang Q, Liu A-L, Du G-H (2016) Discovery of neuroprotective compounds by machine learning approaches. RSC Adv 6(12):9857\u20139871","journal-title":"RSC Adv"},{"issue":"6","key":"14_CR165","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/ci010132r","volume":"42","author":"JL Durant","year":"2002","unstructured":"Durant JL, Leland BA, Henry DR, Nourse JG (2002) Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci 42(6):1273\u20131280","journal-title":"J Chem Inf Comput Sci"},{"issue":"5","key":"14_CR166","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50(5):742\u2013754","journal-title":"J Chem Inf Model"},{"issue":"7428","key":"14_CR167","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard J, Ruda GF, Setola V, Abecassis K, Rodriguiz RM, Huang XP, Norval S, Sassano MF, Shin AI, Webster LA, Simeons FR, Stojanovski L, Prat A, Seidah NG, Constam DB, Bickerton GR, Read KD, Wetsel WC, Gilbert IH, Roth BL, Hopkins AL (2012) Automated design of ligands to polypharmacological profiles. Nature 492(7428):215\u2013220","journal-title":"Nature"},{"issue":"2","key":"14_CR168","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1567205011310020001","volume":"10","author":"A Speck-Planche","year":"2013","unstructured":"Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MNDS (2013) Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors. Curr Alzheimer Res 10(2):117\u2013124","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"14_CR169","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.bmc.2013.01.035","volume":"21","author":"F Luan","year":"2013","unstructured":"Luan F, Cordeiro MNDS, Alonso N, Garcia-Mera X, Caamano O, Romero-Duran FJ, Yanez M, Gonzalez-Diaz H (2013) TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg Med Chem 21(7):1870\u20131879","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"14_CR170","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/cn400111n","volume":"4","author":"N Alonso","year":"2013","unstructured":"Alonso N, Caamano O, Romero-Duran FJ, Luan F, Cordeiro MNDS, Yanez M, Gonzalez-Diaz H, Garcia-Mera X (2013) Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates. ACS Chem Neurosci 4(10):1393\u20131403","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"14_CR171","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.3390\/ijms150917035","volume":"15","author":"FJ Romero Duran","year":"2014","unstructured":"Romero Duran FJ, Alonso N, Caamano O, Garcia-Mera X, Yanez M, Prado-Prado FJ, Gonzalez-Diaz H (2014) Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates. Int J Mol Sci 15(9):17035\u201317064","journal-title":"Int J Mol Sci"},{"key":"14_CR172","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejmech.2013.12.028","volume":"75","author":"OM Bautista-Aguilera","year":"2014","unstructured":"Bautista-Aguilera OM, Esteban G, Bolea I, Nikolic K, Agbaba D, Moraleda I, Iriepa I, Samadi A, Soriano E, Unzeta M, Marco-Contelles J (2014) Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase\/monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease. Eur J Med Chem 75:82\u201395","journal-title":"Eur J Med Chem"},{"key":"14_CR173","first-page":"1893","volume":"8","author":"OM Bautista-Aguilera","year":"2014","unstructured":"Bautista-Aguilera OM, Esteban G, Chioua M, Nikolic K, Agbaba D, Moraleda I, Iriepa I, Soriano E, Samadi A, Unzeta M, Marco-Contelles J (2014) Multipotent cholinesterase\/monoamine oxidase inhibitors for the treatment of Alzheimer\u2019s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. Drug Des Devel Ther 8:1893\u20131910","journal-title":"Drug Des Devel Ther"},{"key":"14_CR174","unstructured":"http:\/\/www.moldiscovery.com\/soft_pentacle.php"},{"issue":"suppl C","key":"14_CR175","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtice.2014.09.017","volume":"46","author":"K Nikolic","year":"2015","unstructured":"Nikolic K, Agbaba D, Stark H (2015) Pharmacophore modeling, drug design and virtual screening on multi-targeting procognitive agents approaching histaminergic pathways. J Taiwan Inst Chem Eng 46(suppl C):15\u201329","journal-title":"J Taiwan Inst Chem Eng"},{"issue":"2","key":"14_CR176","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10822-014-9816-1","volume":"29","author":"K Nikolic","year":"2015","unstructured":"Nikolic K, Mavridis L, Bautista-Aguilera OM, Marco-Contelles J, Stark H, do Carmo Carreiras M, Rossi I, Massarelli P, Agbaba D, Ramsay RR, Mitchell JB (2015) Predicting targets of compounds against neurological diseases using cheminformatic methodology. J Comput Aided Mol Des 29(2):183\u2013198","journal-title":"J Comput Aided Mol Des"},{"issue":"24","key":"14_CR177","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1016\/j.bmc.2008.10.059","volume":"16","author":"W Huang","year":"2008","unstructured":"Huang W, Yu H, Sheng R, Li J, Hu Y (2008) Identification of pharmacophore model, synthesis and biological evaluation of N-phenyl-1-arylamide and N-phenylbenzenesulfonamide derivatives as BACE 1 inhibitors. Bioorg Med Chem 16(24):10190\u201310197","journal-title":"Bioorg Med Chem"},{"issue":"15","key":"14_CR178","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1016\/j.bmc.2010.06.042","volume":"18","author":"W Huang","year":"2010","unstructured":"Huang W, Lv D, Yu H, Sheng R, Kim SC, Wu P, Luo K, Li J, Hu Y (2010) Dual-target-directed 1,3-diphenylurea derivatives: BACE 1 inhibitor and metal chelator against Alzheimer\u2019s disease. Bioorg Med Chem 18(15):5610\u20135615","journal-title":"Bioorg Med Chem"},{"issue":"23","key":"14_CR179","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1016\/j.bmc.2011.09.061","volume":"19","author":"W Huang","year":"2011","unstructured":"Huang W, Tang L, Shi Y, Huang S, Xu L, Sheng R, Wu P, Li J, Zhou N, Hu Y (2011) Searching for the multi-target-directed ligands against Alzheimer\u2019s disease: discovery of quinoxaline-based hybrid compounds with AChE, H(3)R and BACE 1 inhibitory activities. Bioorg Med Chem 19(23):7158\u20137167","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"14_CR180","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14756366.2016.1265521","volume":"32","author":"Q Xie","year":"2017","unstructured":"Xie Q, Zheng Z, Shao B, Fu W, Xia Z, Li W, Sun J, Zheng W, Zhang W, Sheng W, Zhang Q, Chen H, Wang H, Qiu Z (2017) Pharmacophore-based design and discovery of (\u2212)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis. J Enzyme Inhib Med Chem 32(1):659\u2013671","journal-title":"J Enzyme Inhib Med Chem"},{"key":"14_CR181","doi-asserted-by":"crossref","unstructured":"Bhayye SS, Roy K, Saha A (2016) Pharmacophore generation, atom-based 3D-QSAR, HQSAR and activity cliff analyses of benzothiazine and deazaxanthine derivatives as dual A2A antagonists\/MAOB inhibitors. SAR QSAR Environ Res:1\u201320","DOI":"10.1080\/1062936X.2015.1136840"},{"key":"14_CR182","series-title":"ACS symposium series","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1021\/bk-1999-0719.ch014","volume-title":"Rational drug design","author":"TW Heritage","year":"1999","unstructured":"Heritage TW, Lowis DR (1999) Molecular hologram QSAR. In: Rational drug design, ACS symposium series, vol vol 719. American Chemical Society, Washington, DC, pp 212\u2013225"},{"issue":"5","key":"14_CR183","first-page":"359","volume":"1","author":"NC Inestrosa","year":"1996","unstructured":"Inestrosa NC, Alvarez A, Calderon F (1996) Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer\u2019s filaments. Mol Psychiatry 1(5):359\u2013361","journal-title":"Mol Psychiatry"},{"issue":"3","key":"14_CR184","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","volume":"65","author":"M Bartolini","year":"2003","unstructured":"Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65(3):407\u2013416","journal-title":"Biochem Pharmacol"},{"key":"14_CR185","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","volume":"151","author":"L Ismaili","year":"2017","unstructured":"Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J (2017) Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer\u2019s disease. Prog Neurobiol 151:4\u201334","journal-title":"Prog Neurobiol"},{"issue":"7","key":"14_CR186","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bmc.2016.02.023","volume":"24","author":"SS Xie","year":"2016","unstructured":"Xie SS, Lan JS, Wang X, Wang ZM, Jiang N, Li F, Wu JJ, Wang J, Kong LY (2016) Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 24(7):1528\u20131539","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"14_CR187","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1039\/C3OB42010H","volume":"12","author":"SY Li","year":"2014","unstructured":"Li SY, Jiang N, Xie SS, Wang KD, Wang XB, Kong LY (2014) Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease. Org Biomol Chem 12(5):801\u2013814","journal-title":"Org Biomol Chem"},{"key":"14_CR188","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","volume":"95","author":"SS Xie","year":"2015","unstructured":"Xie SS, Wang X, Jiang N, Yu W, Wang KD, Lan JS, Li ZR, Kong LY (2015) Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer\u2019s disease. Eur J Med Chem 95:153\u2013165","journal-title":"Eur J Med Chem"},{"issue":"5","key":"14_CR189","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/anie.201410456","volume":"54","author":"F Prati","year":"2015","unstructured":"Prati F, De Simone A, Bisignano P, Armirotti A, Summa M, Pizzirani D, Scarpelli R, Perez DI, Andrisano V, Perez-Castillo A, Monti B, Massenzio F, Polito L, Racchi M, Favia AD, Bottegoni G, Martinez A, Bolognesi ML, Cavalli A (2015) Multitarget drug discovery for Alzheimer\u2019s disease: triazinones as BACE-1 and GSK-3beta inhibitors. Angew Chem Int Ed Engl 54(5):1578\u20131582","journal-title":"Angew Chem Int Ed Engl"},{"key":"14_CR190","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejmech.2017.10.050","volume":"143","author":"S Carradori","year":"2018","unstructured":"Carradori S, Ortuso F, Petzer A, Bagetta D, De Monte C, Secci D, De Vita D, Guglielmi P, Zengin G, Aktumsek A, Alcaro S, Petzer JP (2018) Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. Eur J Med Chem 143:1543\u20131552","journal-title":"Eur J Med Chem"},{"issue":"9","key":"14_CR191","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1021\/jm801292b","volume":"52","author":"J Marco-Contelles","year":"2009","unstructured":"Marco-Contelles J, Leon R, de los Rios C, Samadi A, Bartolini M, Andrisano V, Huertas O, Barril X, Luque FJ, Rodriguez-Franco MI, Lopez B, Lopez MG, Garcia AG, Carreiras Mdo C, Villarroya M (2009) Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease. J Med Chem 52(9):2724\u20132732","journal-title":"J Med Chem"},{"issue":"1","key":"14_CR192","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/ijms17010113","volume":"17","author":"Zhijie Cui","year":"2016","unstructured":"Cui Z, Sheng Z, Yan X, Cao Z, Tang K (2016) In silico insight into potential anti-Alzheimer\u2019s disease mechanisms of icariin. Int J Mol Sci 17(1). https:\/\/doi.org\/10.3390\/ijms17010113","journal-title":"International Journal of Molecular Sciences"},{"key":"14_CR193","unstructured":"http:\/\/www.cbligand.org\/AD\/"},{"issue":"4","key":"14_CR194","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/ci500004h","volume":"54","author":"H Liu","year":"2014","unstructured":"Liu H, Wang L, Lv M, Pei R, Li P, Pei Z, Wang Y, Su W, Xie XQ (2014) AlzPlatform: an Alzheimer\u2019s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research. J Chem Inf Model 54(4):1050\u20131060","journal-title":"J Chem Inf Model"},{"key":"14_CR195","unstructured":"www.CBLIgand.org\/CBID"},{"key":"14_CR196","unstructured":"http:\/\/www.mysql.com"},{"key":"14_CR197","unstructured":"http:\/\/www.apache.org\/"},{"key":"14_CR198","unstructured":"http:\/\/openbabel.org\/wiki\/Main_Page"},{"key":"14_CR199","unstructured":"www.cbligand.org\/TargetHunter"},{"key":"14_CR200","unstructured":"http:\/\/www.cbligand.org\/HTDocking\/"},{"key":"14_CR201","unstructured":"http:\/\/www.cbligand.org\/BBB\/"},{"key":"14_CR202","unstructured":"http:\/\/rcidm.org\/AlzhCPI"},{"issue":"5","key":"14_CR203","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178347","volume":"12","author":"J Fang","year":"2017","unstructured":"Fang J, Wang L, Li Y, Lian W, Pang X, Wang H, Yuan D, Wang Q, Liu AL, Du GH (2017) AlzhCPI: a knowledge base for predicting chemical-protein interactions towards Alzheimer\u2019s disease. PLoS One 12(5):e0178347","journal-title":"PLoS One"},{"issue":"1","key":"14_CR204","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/bib\/bbw004","volume":"18","author":"T Qiu","year":"2017","unstructured":"Qiu T, Qiu J, Feng J, Wu D, Yang Y, Tang K, Cao Z, Zhu R (2017) The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope. Brief Bioinform 18(1):125\u2013136","journal-title":"Brief Bioinform"},{"issue":"6","key":"14_CR205","first-page":"1070","volume":"17","author":"F Barneh","year":"2016","unstructured":"Barneh F, Jafari M, Mirzaie M (2016) Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database. Brief Bioinform 17(6):1070\u20131080","journal-title":"Brief Bioinform"},{"key":"14_CR206","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13321-015-0064-8","volume":"7","author":"C Chen","year":"2015","unstructured":"Chen C, He Y, Wu J, Zhou J (2015) Creation of a free, internet-accessible database: the multiple target ligand database. J Cheminform 7:14","journal-title":"J Cheminform"},{"issue":"11","key":"14_CR207","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","volume":"13","author":"S Alqahtani","year":"2017","unstructured":"Alqahtani S (2017) In silico ADME-Tox modeling: progress and prospects. Expert Opin Drug Metab Toxicol 13(11):1147\u20131158","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Methods in Pharmacology and Toxicology","Multi-Target Drug Design Using Chem-Bioinformatic Approaches"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7653_2018_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T23:18:18Z","timestamp":1649805498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7653_2018_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493987320","9781493987337"],"references-count":207,"URL":"https:\/\/doi.org\/10.1007\/7653_2018_14","relation":{},"ISSN":["1557-2153","1940-6053"],"issn-type":[{"type":"print","value":"1557-2153"},{"type":"electronic","value":"1940-6053"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"19 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}